CCCC
Price
$1.40
Change
-$0.12 (-7.89%)
Updated
Jun 27 closing price
Capitalization
99.41M
37 days until earnings call
CTNM
Price
$4.11
Change
+$0.10 (+2.49%)
Updated
Jun 27 closing price
Capitalization
106.33M
50 days until earnings call
Interact to see
Advertisement

CCCC vs CTNM

Header iconCCCC vs CTNM Comparison
Open Charts CCCC vs CTNMBanner chart's image
C4 Therapeutics
Price$1.40
Change-$0.12 (-7.89%)
Volume$8.25M
Capitalization99.41M
Contineum Therapeutics
Price$4.11
Change+$0.10 (+2.49%)
Volume$1.31M
Capitalization106.33M
CCCC vs CTNM Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. CTNM commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Buy and CTNM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CCCC: $1.40 vs. CTNM: $4.12)
Brand notoriety: CCCC and CTNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 691% vs. CTNM: 907%
Market capitalization -- CCCC: $99.41M vs. CTNM: $106.33M
CCCC [@Biotechnology] is valued at $99.41M. CTNM’s [@Biotechnology] market capitalization is $106.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileCTNM’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • CTNM’s FA Score: 1 green, 4 red.
According to our system of comparison, CTNM is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while CTNM’s TA Score has 2 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 6 bearish.
  • CTNM’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than CTNM.

Price Growth

CCCC (@Biotechnology) experienced а -1.41% price change this week, while CTNM (@Biotechnology) price change was -13.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

CTNM is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTNM($106M) has a higher market cap than CCCC($99.4M). CCCC YTD gains are higher at: -61.111 vs. CTNM (-71.877). CTNM has higher annual earnings (EBITDA): -50.16M vs. CCCC (-102.74M). CCCC has more cash in the bank: 215M vs. CTNM (191M). CTNM has less debt than CCCC: CTNM (6M) vs CCCC (64.4M). CCCC has higher revenues than CTNM: CCCC (39.8M) vs CTNM (0).
CCCCCTNMCCCC / CTNM
Capitalization99.4M106M94%
EBITDA-102.74M-50.16M205%
Gain YTD-61.111-71.87785%
P/E RatioN/A26.40-
Revenue39.8M0-
Total Cash215M191M113%
Total Debt64.4M6M1,073%
TECHNICAL ANALYSIS
Technical Analysis
CCCCCTNM
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
72%
Advances
ODDS (%)
Bullish Trend 18 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JBAXY13.400.16
+1.21%
Julius Baer Group Ltd.
SPHRF0.07N/A
N/A
Starpharma Holdings Ltd.
BMYMP801.01N/A
N/A
Bristol-Myers Squibb Co.
MDALF25.05-0.09
-0.36%
MDA Space Ltd.
CLVLY6.80-0.18
-2.58%
Clinuvel Pharmaceuticals Ltd.

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-7.89%
KYMR - CCCC
56%
Loosely correlated
-3.48%
CRBU - CCCC
55%
Loosely correlated
-6.67%
BEAM - CCCC
53%
Loosely correlated
-1.98%
FATE - CCCC
52%
Loosely correlated
-5.45%
RXRX - CCCC
51%
Loosely correlated
-6.85%
More

CTNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTNM has been loosely correlated with CCCC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CTNM jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
+2.74%
CCCC - CTNM
36%
Loosely correlated
-7.89%
XNCR - CTNM
31%
Poorly correlated
-3.10%
VYGR - CTNM
31%
Poorly correlated
-0.34%
GBIO - CTNM
31%
Poorly correlated
-15.40%
ARMP - CTNM
30%
Poorly correlated
+4.71%
More